1
|
Espitia-Pérez P, Espitia-Pérez L, Peñata-Taborda A, Brango H, Pastor-Sierra K, Galeano-Páez C, Arteaga-Arroyo G, Humanez-Alvarez A, Rodríguez Díaz R, Salas Osorio J, Valderrama LA, Saint’Pierre TD. Genetic Damage and Multi-Elemental Exposure in Populations in Proximity to Artisanal and Small-Scale Gold (ASGM) Mining Areas in North Colombia. TOXICS 2025; 13:202. [PMID: 40137529 PMCID: PMC11946375 DOI: 10.3390/toxics13030202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/25/2024] [Revised: 01/24/2025] [Accepted: 01/26/2025] [Indexed: 03/29/2025]
Abstract
This study evaluates DNA damage and multi-element exposure in populations from La Mojana, a region of North Colombia heavily impacted by artisanal and small-scale gold mining (ASGM). DNA damage markers from the cytokinesis-block micronucleus cytome (CBMN-Cyt) assay, including micronucleated binucleated cells (MNBN), nuclear buds (NBUDs) and nucleoplasmic bridges (NPB), were assessed in 71 exposed individuals and 37 unexposed participants. Exposed individuals had significantly higher MNBN frequencies (PR = 1.26, 95% CI: 1.02-1.57, p = 0.039). Principal Component Analysis (PCA) identified the "Soil-Derived Mining-Associated Elements" (PC1), including V, Fe, Al, Co, Ba, Se and Mn, as being strongly associated with high MNBN frequencies in the exposed population (PR = 10.45, 95% CI: 9.75-12.18, p < 0.001). GAMLSS modeling revealed non-linear effects of PC1, with greater increases in MNBN at higher concentrations, especially in exposed individuals. These results highlight the dual role of essential and toxic elements, with low concentrations being potentially protective but higher concentrations increasing genotoxicity. Women consistently exhibited higher MNBN frequencies than men, suggesting sex-specific susceptibilities. This study highlights the compounded risks of chronic metal exposure in mining-impacted regions and underscores the urgent need for targeted interventions to mitigate genotoxic risks in vulnerable populations.
Collapse
Affiliation(s)
- Pedro Espitia-Pérez
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Lyda Espitia-Pérez
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Ana Peñata-Taborda
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Hugo Brango
- Facultad de Educación y Ciencias, Departamento de Matemáticas, Universidad de Sucre, Sincelejo 700003, Colombia;
| | - Karina Pastor-Sierra
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Claudia Galeano-Páez
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Gean Arteaga-Arroyo
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Alicia Humanez-Alvarez
- Grupo de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería 230001, Colombia; (L.E.-P.); (A.P.-T.); (K.P.-S.); (C.G.-P.); (G.A.-A.); (A.H.-A.)
| | - Ruber Rodríguez Díaz
- Hospital Alma Máter, Unidad de Cuidados Intensivos (UCI), Medellín 050001, Colombia;
| | - Javier Salas Osorio
- Hospital Alma Máter, Servicios Ambulatorios, Coordinación Médica, Medellín 050001, Colombia;
| | | | | |
Collapse
|
2
|
Li JB, Li D, Liu YY, Cao A, Wang H. Cytotoxicity of vanadium dioxide nanoparticles to human embryonic kidney cell line: Compared with vanadium(IV/V) ions. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2024; 106:104378. [PMID: 38295964 DOI: 10.1016/j.etap.2024.104378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2023] [Accepted: 01/24/2024] [Indexed: 02/13/2024]
Abstract
Vanadium dioxide (VO2) is a class of thermochromic material with potential applications in various fields. Massive production and wide application of VO2 raise the concern of its potential toxicity to human, which has not been fully understood. Herein, a commercial VO2 nanomaterial (S-VO2) was studied for its potential toxicity to human embryonic kidney cell line HEK293, and two most common vanadium ions, V(IV) and V(V), were used for comparison to reveal the related mechanism. Our results indicate that S-VO2 induces dose-dependent cellular viability loss mainly through the dissolved V ions of S-VO2 outside the cell rather than S-VO2 particles inside the cell. The dissolved V ions of S-VO2 overproduce reactive oxygen species to trigger apoptosis and proliferation inhibition via several signaling pathways of cell physiology, such as MAPK and PI3K-Akt, among others. All bioassays indicate that the differences in toxicity between S-VO2, V(IV), and V(V) in HEK293 cells are very small, supporting that the toxicity is mainly due to the dissolved V ions, in the form of V(V) and/or V(IV), but the V(V)'s behavior is more similar to S-VO2 according to the gene expression analysis. This study reveals the toxicity mechanism of nanosized VO2 at the molecular level and the role of dissolution of VO2, providing valuable information for safe applications of vanadium oxides.
Collapse
Affiliation(s)
- Jia-Bei Li
- Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China
| | - Dan Li
- Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China
| | - Yuan-Yuan Liu
- Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China
| | - Aoneng Cao
- Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China
| | - Haifang Wang
- Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China.
| |
Collapse
|